Online Tools for Obesity
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate the effectiveness of online tools in aiding weight loss. Participants will be divided into two groups: one will use an online program called Connect4Health Engage, while the other will use Connect4Health Discover, which focuses on education. The trial seeks adults with a BMI of 30 or higher, or 27-29.9 with related health issues such as high blood pressure or diabetes, who have internet access. As an unphased trial, this study offers participants the chance to contribute to innovative research that could improve weight loss strategies through online tools.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently taking prescription medication for weight loss.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that Connect4Health Engage is designed to help and encourage people to use online tools for weight loss. Similar programs have improved health in other studies, which suggest that using community and clinical resources can be effective and safe. Participants usually find these programs manageable, with few unwanted side effects reported. As this trial tests an online program rather than a drug or medical device, it is expected to be well-tolerated. The focus on education and motivation generally poses minimal risk to participants.12345
Why are researchers excited about this trial?
Unlike traditional treatments for obesity that often involve medication, surgery, or in-person therapy, Connect4Health Discover and Connect4Health Engage offer online tools to support weight loss and healthy habits. Researchers are excited about these digital interventions because they make use of personalized feedback and interactive content, which can be accessed conveniently from home. This approach allows for more flexible, continuous support and engagement compared to standard in-clinic visits, potentially increasing patient adherence and success in managing obesity.
What evidence suggests that this trial's treatments could be effective for obesity?
Research has shown that Connect4Health Engage, a program in this trial designed to help people use online tools for weight loss, is promising. Studies suggest that individuals using these tools lost more weight than those who did not. Meanwhile, Connect4Health Discover, another program tested in this trial, aims to improve weight management through structured, supportive online resources. Specifically, one study found that participants in a similar program improved their weight management, indicating that structured, supportive online resources can be effective. These programs assist people in making better lifestyle choices by providing easy access to proven resources. This makes Connect4Health Engage and Connect4Health Discover promising options for those seeking to manage their weight effectively with technology.13456
Are You a Good Fit for This Trial?
This trial is for adults with obesity or weight-related health issues who have internet access and can read English. They must not be enrolled in other weight loss programs, have a BMI under 45 kg/m2, no recent severe cardiovascular events, and not planning to move soon. Pregnant women and those with certain medical conditions like Type 1 Diabetes or active cancer are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants complete either the 52-week Connect4Health Engage intervention or Connect4Health Discover, an educational control
Follow-up
Participants are monitored for weight stability and other health metrics after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Connect4Health Discover
- Connect4Health Engage
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Florida
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator